Metraipolis › archive › dc_bcee22cb0100

Single-domain antibodies as potent inhibitors of clinically relevant β-lactamases in multidrug-resistant bacteria — Europe PMC PMID:42358267

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42358267
DOI: 10.3389/fmicb.2026.1840552
License (as archived): solo-consultazione
Archived: 2026-10-31T14:49:47.143Z
SHA-256 of the archived text: c99725c3f37ecdb6920024f4977c11df669114161b3d4c2eae5e9fad3f1db406
Stable URL of this page: https://metraipolis.com/documento/dc_bcee22cb0100

How to cite

Single-domain antibodies as potent inhibitors of clinically relevant β-lactamases in multidrug-resistant bacteria — Europe PMC PMID:42358267 — Europe PMC (en), https://europepmc.org/article/MED/42358267 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bcee22cb0100 (Metraipolis archive dc_bcee22cb0100, sha256 c99725c3f37ecdb6920024f4977c11df669114161b3d4c2eae5e9fad3f1db406)

BibTeX

@misc{dcbcee22cb0100,
  title = {Single-domain antibodies as potent inhibitors of clinically relevant β-lactamases in multidrug-resistant bacteria — Europe PMC PMID:42358267},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42358267},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bcee22cb0100; sha256 c99725c3f37ecdb6920024f4977c11df669114161b3d4c2eae5e9fad3f1db406},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42358267. Agents can read the archived copy with the MCP tool read_document.